Revised clinical guidance for management of Covid-19 patients-April 22, 2021

Updated - April 23, 2021 at 09:54 AM.

Guidelines issued by AIIMS, ICMR-Covid-19 National Task Force and the Joint Monitoring Group under the health ministry

Medics at Covid care centre at CWC, in New Delhi

The Union Health Ministry on Thursday issued a revised 'Clinical Guidance for Management of Adult Covid-19 Patients' recommending the EUA/off-label use of Tocilizumab drug in case of severe diseases, preferably within 24 to 48 hours of the onset of the disease or ICU admission.

Read:Clinical guidance for management of adult covid-19 patients - April 22, 2021

Published on April 23, 2021 04:08